QHow much time does it take and how much does it cost to successfully develop a hybrid with one or more transgenic traits from conception to commercial release. Can you categorize the portion of costs that are incurred as a result of meeting regulatory ap

How much time does it take and how much does it cost to successfully develop a hybrid with one or more transgenic traits from conception to commercial release. Can you categorize the portion of costs that are incurred as a result of meeting regulatory approvals and those that would be incurred even if there were no regulatory approvals required. My understanding is that it takes several years and tens of millions of dollars to obtain regulatory approvals thus effectively excluding public sector and universities, trade associations and other groups from developing and offering traits in the public domain.

AExpert Answer

You are correct that it requires a tremendous investment of both time and resources to bring a new biotech crop to market. A survey completed in 2011 found the cost of discovery, development and authorization of a new plant biotechnology trait introduced between 2008 and 2012 was $136 million. On average, about 26 percent of those costs ($35.1 million) were incurred as part of the regulatory testing and registration process. The same study found that the average time from initiation of a discovery project to commercial launch is about 13 years. The longest phase of product development is regulatory science and registration activities, at about 5.5 years for traits introduced in 2011.

 

While that price tag is significant, so are the losses from pests, diseases and other issues that these new traits are designed to help farmers combat. For example, the U.S. Department of Agriculture has estimated corn rootworm causes $1 billion dollars in damage to the U.S. corn crop alone each year. By delivering traits that can fight these pests, it increases farmers’ productivity.

 

The high costs of commercializing new plant biotechnology can be a challenge to the public sector, universities and others parties. That is where public-private partnerships are essential. DuPont and DuPont Pioneer have a long tradition of taking a collaborative approach to problem-solving. There are numerous examples of organizations working together to further the development of a promising trait or technology, including DuPont-supported initiatives such as the African Biofortified Sorghum and Improved Maize for African Soils projects.

Posted on September 5, 2017
While there might be some institutions with the capability to make these transgenic watermelon and coconut plants for you, that does not mean that you would be able to actually plant them out. First, the institution would need to have a Biological Use Authorization to work with recombinant DNA to make the vectors to transfer the genes. Then they would need to be able to do the tissue culture required to transfer the genes and regenerate whole plants again, which can sometimes be difficult.... Read More
Posted on June 19, 2017
Yes, the EU is one of the geographies where GM-derived food and animal feed must be labeled according to conditions outlined by the European Commission on this webpage. GM labels are very common on sacks of animal feed. Depending on the type of animal, GM labeled feed is often the standard – except of course when it comes to GM free or organic supply chains. Read More
Answer:
Posted on June 28, 2017
The short answer is no, neither MSG or animal extraction are from GMOs, nor is MSG, animal extraction, or animal products/animal DNA in GMOs.   When people refer to Genetically Modified Organisms (GMOs), they are referring to precision plant breeding using genetic engineering (also called GE). It allows plant breeders to take a desirable trait (like resistance to drought, insects, weeds, and disease) from one plant or organism and transfer it to the plant... Read More
Answer:

Explore More Topics